- Home
- ONCY vs LSBK Comparison
ONCY vs LSBK Comparison
Compare ONCY & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- LSBK
- Stock Information
- Founded
- ONCY 1998
- LSBK 1891
- Country
- ONCY Canada
- LSBK United States
- Employees
- ONCY N/A
- LSBK N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- LSBK Savings Institutions
- Sector
- ONCY Health Care
- LSBK Finance
- Exchange
- ONCY Nasdaq
- LSBK Nasdaq
- Market Cap
- ONCY 89.7M
- LSBK 90.0M
- IPO Year
- ONCY 1999
- LSBK 2006
- Fundamental
- Price
- ONCY $1.06
- LSBK $13.35
- Analyst Decision
- ONCY Strong Buy
- LSBK
- Analyst Count
- ONCY 5
- LSBK 0
- Target Price
- ONCY $5.00
- LSBK N/A
- AVG Volume (30 Days)
- ONCY 681.0K
- LSBK 42.6K
- Earning Date
- ONCY 08-08-2025
- LSBK 10-22-2025
- Dividend Yield
- ONCY N/A
- LSBK 2.73%
- EPS Growth
- ONCY N/A
- LSBK 39.59
- EPS
- ONCY N/A
- LSBK 1.05
- Revenue
- ONCY N/A
- LSBK $26,488,000.00
- Revenue This Year
- ONCY N/A
- LSBK N/A
- Revenue Next Year
- ONCY N/A
- LSBK N/A
- P/E Ratio
- ONCY N/A
- LSBK $12.59
- Revenue Growth
- ONCY N/A
- LSBK 1.75
- 52 Week Low
- ONCY $0.33
- LSBK $11.50
- 52 Week High
- ONCY $1.53
- LSBK $13.38
- Technical
- Relative Strength Index (RSI)
- ONCY 54.04
- LSBK 78.56
- Support Level
- ONCY $0.95
- LSBK $12.00
- Resistance Level
- ONCY $1.07
- LSBK $12.92
- Average True Range (ATR)
- ONCY 0.08
- LSBK 0.16
- MACD
- ONCY 0.01
- LSBK 0.04
- Stochastic Oscillator
- ONCY 81.89
- LSBK 95.66
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.